Research Nester Logo.jpg
Cholangiocarcinoma Market revenue to hit USD 1.3 Billion by 2036, says Research Nester
December 07, 2023 06:30 ET | Research Nester
New York , Dec. 07, 2023 (GLOBE NEWSWIRE) -- The global cholangiocarcinoma market size is projected to grow at a CAGR of over 4% from 2024 to 2036. The market is expected to garner a revenue of USD...
China Oxaliplatin Markets Report 2021
June 22, 2021 05:13 ET | Research and Markets
Dublin, June 22, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Oxaliplatin Market 2021-2025" report has been added to's offering. The sales value of...
The first patient in
The first patient included in PledPharma’s global Phase III program for PledOx®
November 08, 2018 02:00 ET | PledPharma AB
STOCKHOLM, November 8, 2018 — PledPharma AB (publ), a Swedish pharmaceutical developer, today announced that the first patient has been enrolled in the company’s global Phase III program with the...
Första patienten ink
Första patienten inkluderad i PledPharmas globala fas III program för läkemedelskandidaten PledOx®
November 08, 2018 02:00 ET | PledPharma AB
Stockholm, 8 november 2018. PledPharma AB (publ) meddelar i dag att den första patienten inkluderats i USA i det globala fas III‑programmet för läkemedelskandidaten PledOx®. Ett viktigt och för...